Cargando…

Delayed presentation in breast cancer: a study in Iranian women

BACKGROUND: A cross sectional study was conducted in Tehran Iran to examine the extent of patient delay and associated factors in the presentation of breast cancer. METHODS: A group of newly diagnosed breast cancer patients were interviewed and were asked about the period from first onset of symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Montazeri, Ali, Ebrahimi, Mandana, Mehrdad, Neda, Ansari, Mariam, Sajadian, Akram
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC166160/
https://www.ncbi.nlm.nih.gov/pubmed/12846932
http://dx.doi.org/10.1186/1472-6874-3-4
_version_ 1782120855218683904
author Montazeri, Ali
Ebrahimi, Mandana
Mehrdad, Neda
Ansari, Mariam
Sajadian, Akram
author_facet Montazeri, Ali
Ebrahimi, Mandana
Mehrdad, Neda
Ansari, Mariam
Sajadian, Akram
author_sort Montazeri, Ali
collection PubMed
description BACKGROUND: A cross sectional study was conducted in Tehran Iran to examine the extent of patient delay and associated factors in the presentation of breast cancer. METHODS: A group of newly diagnosed breast cancer patients were interviewed and were asked about the period from first onset of symptoms to first medical consultation to indicate patient delay. This was studied in relation to patients' age, educational level, marital status, family history of breast cancer, history of benign breast disease, number of children and the nature of the first symptom seen. RESULTS: In all, 190 breast cancer patients were interviewed. Of these, 75% presented to physician within 3 months. Forty-two patients (25%) delayed more than 3 months. In multivariate regression analysis it was found that there was a risk for longer delay in widowed or divorced women (OR 3.7, 95% CI 1.5–9.7), women with a positive family history of breast cancer (OR 2.8, 95% CI 1.1–7.7), and less educated patients (illiterate: OR 5.2, 95% CI 1.5–17.7; primary schooling: OR 4.6, 95% CI 1.4–14.7). Significant associations also were found between delay presentation and the late stage disease (P = 0.01) and bigger tumor size (P = 0.004). CONCLUSION: The findings suggest that one in four women with breast cancer present late and this has significant effect on their disease prognosis. To reduce patient delay health education programs regarding breast cancer should be implemented and target women who are at higher risk of delay.
format Text
id pubmed-166160
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1661602003-07-26 Delayed presentation in breast cancer: a study in Iranian women Montazeri, Ali Ebrahimi, Mandana Mehrdad, Neda Ansari, Mariam Sajadian, Akram BMC Womens Health Research Article BACKGROUND: A cross sectional study was conducted in Tehran Iran to examine the extent of patient delay and associated factors in the presentation of breast cancer. METHODS: A group of newly diagnosed breast cancer patients were interviewed and were asked about the period from first onset of symptoms to first medical consultation to indicate patient delay. This was studied in relation to patients' age, educational level, marital status, family history of breast cancer, history of benign breast disease, number of children and the nature of the first symptom seen. RESULTS: In all, 190 breast cancer patients were interviewed. Of these, 75% presented to physician within 3 months. Forty-two patients (25%) delayed more than 3 months. In multivariate regression analysis it was found that there was a risk for longer delay in widowed or divorced women (OR 3.7, 95% CI 1.5–9.7), women with a positive family history of breast cancer (OR 2.8, 95% CI 1.1–7.7), and less educated patients (illiterate: OR 5.2, 95% CI 1.5–17.7; primary schooling: OR 4.6, 95% CI 1.4–14.7). Significant associations also were found between delay presentation and the late stage disease (P = 0.01) and bigger tumor size (P = 0.004). CONCLUSION: The findings suggest that one in four women with breast cancer present late and this has significant effect on their disease prognosis. To reduce patient delay health education programs regarding breast cancer should be implemented and target women who are at higher risk of delay. BioMed Central 2003-07-07 /pmc/articles/PMC166160/ /pubmed/12846932 http://dx.doi.org/10.1186/1472-6874-3-4 Text en Copyright © 2003 Montazeri et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Montazeri, Ali
Ebrahimi, Mandana
Mehrdad, Neda
Ansari, Mariam
Sajadian, Akram
Delayed presentation in breast cancer: a study in Iranian women
title Delayed presentation in breast cancer: a study in Iranian women
title_full Delayed presentation in breast cancer: a study in Iranian women
title_fullStr Delayed presentation in breast cancer: a study in Iranian women
title_full_unstemmed Delayed presentation in breast cancer: a study in Iranian women
title_short Delayed presentation in breast cancer: a study in Iranian women
title_sort delayed presentation in breast cancer: a study in iranian women
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC166160/
https://www.ncbi.nlm.nih.gov/pubmed/12846932
http://dx.doi.org/10.1186/1472-6874-3-4
work_keys_str_mv AT montazeriali delayedpresentationinbreastcancerastudyiniranianwomen
AT ebrahimimandana delayedpresentationinbreastcancerastudyiniranianwomen
AT mehrdadneda delayedpresentationinbreastcancerastudyiniranianwomen
AT ansarimariam delayedpresentationinbreastcancerastudyiniranianwomen
AT sajadianakram delayedpresentationinbreastcancerastudyiniranianwomen